Cumberland Pharmaceuticals (CPIX) Non-Current Debt (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Non-Current Debt of $5.2 million for Q1 2026, little changed sequentially from $5.2 million in Q4 2025, and little changed YoY from $5.2 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Non-Current Debt (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Non-Current Debt for 16 years, with the latest figure at $5.2 million in Q1 2026.
- Quarterly Non-Current Debt changed 0.0% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.2 million, down 48.5% from the prior year.
- Non-Current Debt steadied at $5.2 million in Q1 2026 per CPIX's latest filing, from $5.2 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $20.0 million in Q1 2022 and troughed at $5.2 million in Q1 2025.
- A 5-year average of $12.1 million and a median of $12.9 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt jumped 35.71% in 2022, then tumbled 67.43% in 2025.
- Over 5 years, Non-Current Debt stood at $16.2 million in 2022, then fell by 21.09% to $12.8 million in 2023, then declined by 20.4% to $10.2 million in 2024, then tumbled by 48.5% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $5.2 million, $5.2 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.24 Mn |
| Sep 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Sep 30, 2024 | 10.10 Mn |
| Jun 30, 2024 | 16.09 Mn |
| Mar 31, 2024 | 16.08 Mn |
| Dec 31, 2023 | 12.78 Mn |
| Sep 30, 2023 | 12.92 Mn |
| Jun 30, 2023 | 13.15 Mn |
| Mar 31, 2023 | 16.07 Mn |
| Dec 31, 2022 | 16.20 Mn |
| Sep 30, 2022 | 17.70 Mn |
| Jun 30, 2022 | 19.00 Mn |
| Mar 31, 2022 | 20.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 14.00 Mn |